Zentek (ZTEK) Return on Capital Employed (2022 - 2026)
Zentek (ZTEK) posted Return on Capital Employed of 83.5% for Q1 2026, down 68.58% sequentially from 49.53% in Q4 2025, and down 10059.0% YoY from N/an in Q1 2025.
Zentek (ZTEK) Return on Capital Employed (2022 - 2026) Analysis & Trends
Zentek has reported Return on Capital Employed for 5 years, with the latest figure at 83.5% in Q1 2026.
- Quarterly Return on Capital Employed fell 10059.0% year-over-year to 83.5% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 83.5% (down 10059.0% YoY) and the FY2026 annual result came in at 83.46%, down 2814.0% from the prior year.
- Return on Capital Employed slipped to 83.5% in Q1 2026 per ZTEK's latest filing, from 49.53% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 65.24% in Q4 2022 and troughed at 101.82% in Q4 2023.
- A 5-year average of 17.77% and a median of 10.28% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2024: Return on Capital Employed slumped 16707 bps in 2023, then soared 11210 bps in 2024.
- Over 5 years, Return on Capital Employed stood at 65.24% in 2022, then slumped by 256 bps to 101.82% in 2023, then surged by 110 bps to 10.28% in 2024, then tumbled by 582 bps to 49.53% in 2025, then plunged by 69 bps to 83.5% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 83.5%, 49.53%, and 10.55% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.28% |
| 10 | Zentek | 63.90 Mn | 51.90 Mn | - | -25.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -83.50% |
| Dec 31, 2025 | -49.53% |
| Sep 30, 2025 | -10.55% |
| Jun 30, 2025 | 21.72% |
| Mar 31, 2025 | 17.09% |
| Dec 31, 2024 | 10.28% |
| Sep 30, 2024 | 14.32% |
| Jun 30, 2024 | 19.81% |
| Mar 31, 2024 | 13.82% |
| Dec 31, 2023 | -101.82% |
| Sep 30, 2023 | -85.04% |
| Jun 30, 2023 | -71.64% |
| Mar 31, 2023 | -64.04% |
| Dec 31, 2022 | 65.24% |
| Sep 30, 2022 | 37.34% |